In intrahepatic cholangiocarcinoma, a mutation in IDH1 (R132C) suggested that the downregulation of P2RX7 was associated with the release of sEVs (Zhang et al., 2019), further supports that mutations in IDH1 promote the release of sEVs. This evidence concerns the gene P2RX7 and intrahepatic cholangiocarcinoma.